UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 89

Sortiert nach

The Importance of Measuring Ionized Calcium in Characterizing Calcium Status and Diagnosing Primary Hyperparathyroidism

The journal of clinical endocrinology and metabolism, 2012-09, Vol.97 (9), p.3138-3145

2012

Volltextzugriff (PDF)

Cardiometabolic risk in polycystic ovary syndrome: a comparison of different approaches to defining the metabolic syndrome

Human reproduction (Oxford), 2008-10, Vol.23 (10), p.2352-2358

2008

Volltextzugriff (PDF)

Loss of the nuclear receptor corepressor SLIRP compromises male fertility

PloS one, 2013-08, Vol.8 (8), p.e70700-e70700

2013

Volltextzugriff (PDF)

Omega-3 Fatty Acid Supplementation Decreases Liver Fat Content in Polycystic Ovary Syndrome: A Randomized Controlled Trial Employing Proton Magnetic Resonance Spectroscopy

The journal of clinical endocrinology and metabolism, 2009-10, Vol.94 (10), p.3842-3848

2009

Volltextzugriff (PDF)

Induction of lactation in a patient with complete androgen insensitivity syndrome

Endocrinology, diabetes & metabolism case reports, 2023-10, Vol.2023 (4), p.1-4

2023

Volltextzugriff (PDF)

Effect of Testosterone Treatment on Bone Microarchitecture and Bone Mineral Density in Men: A 2-Year RCT

The journal of clinical endocrinology and metabolism, 2021-08, Vol.106 (8), p.e3143-e3158

2021

Volltextzugriff (PDF)

Endocrine Society of Australia position statement on male hypogonadism (part 1): assessment and indications for testosterone therapy

Medical journal of Australia, 2016-08, Vol.205 (4), p.173-178

2016

Volltextzugriff (PDF)

Digenic Congenital Hypogonadotropic Hypogonadism Due to Heterozygous GNRH1 p.R31C and AMHR2 p.G445_L453del Variants

Genes, 2023-05, Vol.14 (6), p.1204

2023

Volltextzugriff (PDF)

A case of catamenial erythema multiforme major successfully treated with goserelin

Endocrinology, diabetes & metabolism case reports, 2023-10, Vol.2023 (4), p.1-3

2023

Volltextzugriff (PDF)

Congenital hypogonadotrophic hypogonadism, induction of minipuberty, and future fertility

Endocrinology, diabetes & metabolism case reports, 2023-07, Vol.2023 (3), p.1-5

2023

Volltextzugriff (PDF)

Endocrine consequences of breast cancer therapy and survivorship

Climacteric : the journal of the International Menopause Society, 2024-08, Vol.27 (4), p.333-339

2024

Volltextzugriff (PDF)

Clustering of metabolic and cardiovascular risk factors in the polycystic ovary syndrome: a principal component analysis

Metabolism, clinical and experimental, 2014-08, Vol.63 (8), p.1071-1077

2014

Volltextzugriff (PDF)

Small Changes in Thyroxine Dosage Do Not Produce Measurable Changes in Hypothyroid Symptoms, Well-Being, or Quality of Life: Results of a Double-Blind, Randomized Clinical Trial

The journal of clinical endocrinology and metabolism, 2006-07, Vol.91 (7), p.2624-2630

2006

Volltextzugriff (PDF)

Dissociation of endothelial function and arterial stiffness in nonobese women with polycystic ovary syndrome (PCOS)

Clinical endocrinology (Oxford), 2009-12, Vol.71 (6), p.808-814

2009

Volltextzugriff (PDF)

Erratum to: Favourable effects of fenofibrate on lipids and cardiovascular disease in women with type 2 diabetes: results from the Fenofibrate Intervention and Event Lowering in Diabetes (FIELD) study

Diabetologia, 2015-09, Vol.58 (9), p.2200-2200

2015

Volltextzugriff (PDF)

Combined Thyroxine/Liothyronine Treatment Does Not Improve Well-Being, Quality of Life, or Cognitive Function Compared to Thyroxine Alone: A Randomized Controlled Trial in Patients with Primary Hypothyroidism

The journal of clinical endocrinology and metabolism, 2003-10, Vol.88 (10), p.4543-4550

2003

Volltextzugriff (PDF)

Functional Deletion of the Calcium-Sensing Receptor in a Case of Neonatal Severe Hyperparathyroidism

The journal of clinical endocrinology and metabolism, 2004-08, Vol.89 (8), p.3721-3730

2004

Volltextzugriff (PDF)

Q-122 as a novel, non-hormonal, oral treatment for vasomotor symptoms in women taking tamoxifen or an aromatase inhibitor after breast cancer: a phase 2, randomised, double-blind, placebo-controlled trial

The Lancet (British edition), 2022-11, Vol.400 (10364), p.1704-1711

2022

Volltextzugriff (PDF)

Clinical audit of estradiol implant therapy: long duration of action and implications in non-hysterectomised women

Maturitas, 2016-12, Vol.94, p.84-86

2016

Volltextzugriff (PDF)

Assessment and management of polycystic ovary syndrome: summary of an evidence‐based guideline

Medical journal of Australia, 2011-09, Vol.195 (6), p.S65-S112

2011

Volltextzugriff (PDF)

Serum 21-Deoxycortisol for Diagnosis of Nonclassic Congenital Adrenal Hyperplasia in Women With Androgen Excess

The journal of clinical endocrinology and metabolism, 2023-12, Vol.108 (12), p.e1560-e1570

2023

Volltextzugriff (PDF)

Polycystic ovarian syndrome: marked differences between endocrinologists and gynaecologists in diagnosis and management

Clinical endocrinology (Oxford), 2005-03, Vol.62 (3), p.289-295

2005

Volltextzugriff (PDF)

Erectile dysfunction predicts generalised cardiovascular disease: Evidence from a case–control study

Atherosclerosis, 2007-10, Vol.194 (2), p.458-464

2007

Volltextzugriff (PDF)

Evaluation of 28-day estradiol and progesterone vaginal rings in a phase 1 clinical pharmacokinetic study

Menopause (New York, N.Y.), 2023-04, Vol.30 (4), p.427

2023

Volltextzugriff (PDF)

Letter to the Editor: “Lipid Management in Patients with Endocrine Disorders: An Endocrine Society Clinical Practice Guideline”

The journal of clinical endocrinology and metabolism, 2021-04, Vol.106 (4), p.e1917-e1918

2021

Volltextzugriff (PDF)

1 – 25 von 89

Suche als RSS-Feed

Aktive Filter

ThemaDiabetes

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(84)
Mit Volltextzugriff
(76)

Publikationsform

Artikel
(87)
Berichte
(2)

Sprache

Englisch
(89)
Japanisch
(3)

Erscheinungsjahr

n.n

Thema

Science & Technology
(63)
Life Sciences & Biomedicine
(61)
Humans
(55)
Female
(41)
Biological And Medical Sciences
(30)
Medical Sciences
(30)
Adult
(29)
Endocrinology & Metabolism
(24)
Male
(24)
Middle Aged
(23)
General & Internal Medicine
(13)
Medicine, General & Internal
(13)
Aged
(12)
Endocrinopathies
(12)
Obstetrics & Gynecology
(11)
Polycystic Ovary Syndrome
(10)
Fundamental And Applied Biological Sciences. Psychology
(9)
Gynecology. Andrology. Obstetrics
(9)
Risk Factors
(9)
Double-Blind Method
(8)

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(2)

Menü

Weitere Dienste

Einstellungen

The Importance of Measuring Ionized Calcium in Characterizing Calcium Status and Diagnosing Primary Hyperparathyroidism

Cardiometabolic risk in polycystic ovary syndrome: a comparison of different approaches to defining the metabolic syndrome

Loss of the nuclear receptor corepressor SLIRP compromises male fertility

Omega-3 Fatty Acid Supplementation Decreases Liver Fat Content in Polycystic Ovary Syndrome: A Randomized Controlled Trial Employing Proton Magnetic Resonance Spectroscopy

Induction of lactation in a patient with complete androgen insensitivity syndrome

Effect of Testosterone Treatment on Bone Microarchitecture and Bone Mineral Density in Men: A 2-Year RCT

Endocrine Society of Australia position statement on male hypogonadism (part 1): assessment and indications for testosterone therapy

Digenic Congenital Hypogonadotropic Hypogonadism Due to Heterozygous GNRH1 p.R31C and AMHR2 p.G445_L453del Variants

A case of catamenial erythema multiforme major successfully treated with goserelin

Congenital hypogonadotrophic hypogonadism, induction of minipuberty, and future fertility

Endocrine consequences of breast cancer therapy and survivorship

Clustering of metabolic and cardiovascular risk factors in the polycystic ovary syndrome: a principal component analysis

Small Changes in Thyroxine Dosage Do Not Produce Measurable Changes in Hypothyroid Symptoms, Well-Being, or Quality of Life: Results of a Double-Blind, Randomized Clinical Trial

Dissociation of endothelial function and arterial stiffness in nonobese women with polycystic ovary syndrome (PCOS)

Erratum to: Favourable effects of fenofibrate on lipids and cardiovascular disease in women with type 2 diabetes: results from the Fenofibrate Intervention and Event Lowering in Diabetes (FIELD) study

Combined Thyroxine/Liothyronine Treatment Does Not Improve Well-Being, Quality of Life, or Cognitive Function Compared to Thyroxine Alone: A Randomized Controlled Trial in Patients with Primary Hypothyroidism

Functional Deletion of the Calcium-Sensing Receptor in a Case of Neonatal Severe Hyperparathyroidism

Q-122 as a novel, non-hormonal, oral treatment for vasomotor symptoms in women taking tamoxifen or an aromatase inhibitor after breast cancer: a phase 2, randomised, double-blind, placebo-controlled trial

Clinical audit of estradiol implant therapy: long duration of action and implications in non-hysterectomised women

Assessment and management of polycystic ovary syndrome: summary of an evidence‐based guideline

Serum 21-Deoxycortisol for Diagnosis of Nonclassic Congenital Adrenal Hyperplasia in Women With Androgen Excess

Polycystic ovarian syndrome: marked differences between endocrinologists and gynaecologists in diagnosis and management

Erectile dysfunction predicts generalised cardiovascular disease: Evidence from a case–control study

Evaluation of 28-day estradiol and progesterone vaginal rings in a phase 1 clinical pharmacokinetic study

Letter to the Editor: “Lipid Management in Patients with Endocrine Disorders: An Endocrine Society Clinical Practice Guideline”

Aktive Filter

Suchergebnisse filtern